Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Reality Check

<< Previous

Bullboard Posts

Next >>

Comment by CMHarring218431on Aug 09, 2023 10:59am

177 Views

Post# 35579512

RE:RE:RE:Reality Check

I'm certainly not one to comment on the science here. Admittedly, someone(s) bailing on this stock. Do they know something....I don't think so. My opinion only. I do know a little about how the market makers think and operate. Other than the usual hype and much anticipated success by a bunch of folks.... they see a window where they can walk it down with no imminent news

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing